Similarly, in a study of 17,908 patients with COVID-19 from the National COVID Cohort Collaborative (N3C), individuals exposed to S1R agonist SSRIs showed a 29% reduction in relative risk of long-COVID [17]. The gene discussed is TMBIM4; the disease is COVID-19.